-
Balancing Innovation and Affordability: Health System Trade-offs in Thailand’s Reimbursement Restriction Policies for High-Cost Medicines
Jun 10, 2025, 14:01 PM -
Assessing the Cost-Utility of Lecanemab for Early Alzheimer's Disease Treatment and the Need for Real-World Evidence: A Singapore Perspective
Jun 10, 2025, 14:01 PM -
Left Atrial Appendage Occlusion Versus Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Randomized Controlled Trials
Jun 10, 2025, 14:01 PM -
Characterising the Latency Period of Secondary Primary Malignancy and Lymphoma Onset Following Tisagenlecleucel (CAR-T Cell Therapy): A Real-World Data Analysis
Jun 10, 2025, 14:01 PM -
Using Real World Data to Estimate the Cost of Cardiac Implantable Electronic Device (CIED) Infection in a High-Risk Australian Population
Jun 10, 2025, 14:01 PM -
Generating Real-World Utility Values for Pediatric Health States in Taiwan: A Nationwide EQ-5D-Y-3L Valuation Study Using Composite Time Trade-Off
Jun 10, 2025, 14:01 PM -
From Infection to Recovery: Health-Related Quality of Life Trajectories Among COVID-19 Patients in Selangor
Jun 10, 2025, 14:01 PM -
Estimating Healthcare Costs Associated With Ischemic Heart Disease and Stroke Using Several Different Statistical Models
Jun 10, 2025, 14:01 PM -
Comparative Analysis of Medication Value Sets Across Reference Sources to Ensure Complete Coverage for Real World Evidence Studies
Jun 10, 2025, 14:01 PM -
Healthcare Utilization Patterns in Early-Stage Breast Cancer Taiwanese Patients: A Real World Evidence-Based Subtype-Specific Study
Jun 10, 2025, 14:01 PM -
Burden of Intravenous Immunoglobulin Use Among Adults With Generalized Myasthenia Gravis in Japan
Jun 10, 2025, 14:01 PM -
Characteristics and Accessibility of Orphan Drugs Through 2017-2024 National Drug Price Negotiation in China
Jun 10, 2025, 14:01 PM -
Availability of Nationally Negotiated Orphan Drugs in China: A Temporal Analysis in 2018-2023
Jun 10, 2025, 14:01 PM -
Development of Pharmacoeconomic Evidence for Inflammatory Bowel Disease in China: A Systematic Review
Jun 10, 2025, 14:01 PM -
Real-World Cross-Sectional Study of Clinical Characteristics and Healthcare Resource Utilization in Patients With Generalized Myasthenia Gravis Across the Asia-Pacific Region
Jun 10, 2025, 14:01 PM -
Evaluating the Influence of Single-Arm Trials on Health Technology Assessment (HTA) Decisions: A Comparative Analysis Across Canada, France, England, and Australia
Jun 10, 2025, 14:01 PM -
Are External Control Arms Controlling Anything? A Critical Assessment of the State of the Art In Using RWE in Regulatory Process
Jun 10, 2025, 14:01 PM -
Preferences and Willingness to Pay for Maintenance Inhalers Among Adults With Chronic Obstructive Pulmonary Disease in Thailand: A Discrete Choice Experiment
Jun 10, 2025, 14:01 PM -
Cost-Effectiveness of Dostarlimab Plus Chemotherapy for Primary Advanced or Recurrent Endometrial Cancer From Taiwan’s National Health Insurance Perspective
Jun 10, 2025, 14:01 PM -
Pharmaceutical Approaches to Enhancing RWE Data Collected in Non-Interventional Studies
Jun 10, 2025, 14:01 PM